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variation influencing body mass index: a combined
SNP and CNV analysis
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John I Nurnberger Jr6, Howard J Edenberg7, Danielle M Dick8 and Bradley T Webb9
Abstract
Background: As the architecture of complex traits incorporates a widening spectrum of genetic variation, analyses
integrating common and rare variation are needed. Body mass index (BMI) represents a model trait, since common
variation shows robust association but accounts for a fraction of the heritability. A combined analysis of single
nucleotide polymorphisms (SNP) and copy number variation (CNV) was performed using 1850 European and 498
African-Americans from the Study of Addiction: Genetics and Environment. Genetic risk sum scores (GRSS) were
constructed using 32 BMI-validated SNPs and aggregate-risk methods were compared: count versus weighted and
proxy versus imputation.
Results: The weighted SNP-GRSS constructed from imputed probabilities of risk alleles performed best and was
highly associated with BMI (p = 4.3×10−16) accounting for 3% of the phenotypic variance. In addition to BMI-validated
SNPs, common and rare BMI/obesity-associated CNVs were identified from the literature. Of the 84 CNVs previously
reported, only 21-kilobase deletions on 16p12.3 showed evidence for association with BMI (p = 0.003, frequency = 16.9%),
with two CNVs nominally associated with class II obesity, 1p36.1 duplications (OR = 3.1, p = 0.009, frequency 1.2%) and
5q13.2 deletions (OR = 1.5, p = 0.048, frequency 7.7%). All other CNVs, individually and in aggregate, were not associated
with BMI or obesity. The combined model, including covariates, SNP-GRSS, and 16p12.3 deletion accounted for 11.5% of
phenotypic variance in BMI (3.2% from genetic effects). Models significantly predicted obesity classification with maximum
discriminative ability for morbid-obesity (p = 3.15×10−18).
Conclusion: Results show that incorporating validated effect sizes and allelic probabilities improve prediction
algorithms. Although rare-CNVs did not account for significant phenotypic variation, results provide a framework
for integrated analyses.
Keywords: Body mass index, Obesity, Genome-wide association, Copy number variation, Risk prediction,
Polygenic score, FTO, MC4R
Background
Obesity, defined clinically by a body mass index (BMI) ≥
30 kg/m2, is a serious public health problem that occurs in
over 1/3 of American adults [1,2] and is associated with nu-
merous medical conditions including cardiovascular disease
[3], type II diabetes [4], and cancer [5]. Although nutritional
intake and physical activity are known to affect relative
body weight, twin and family studies have consistently
shown a significant genetic contribution to body compos-
ition with heritability estimates of 40 to 70% [6].
Genome-wide association studies (GWAS) have success-
fully identified single nucleotide polymorphisms (SNPs)
that contribute to individual variation in BMI and common
obesity [7,8]. In general adult populations of European des-
cent, there are 32 SNPs showing robustly replicated associ-
ation with BMI. However, individual variants have relatively
small effects (0.06 to 0.39 kg/m2 in BMI per risk allele
among Europeans) and in aggregate account for only a
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limited proportion of the phenotypic variance (~1.45%) [9].
GWAS of BMI in populations of African ancestry are
limited but initial reports suggest a portion of the
European-associated variants may also be associated
across diverse populations [10-14].
Whereas reported single marker associations account
for only a limited fraction of trait variance, linear mixed
model approaches simultaneously consider the effects of
common variation across the entire genome. As applied
to BMI, this approach has demonstrated that common
SNPs account for up to 17% of the phenotypic variance
in BMI [15]. However, given that reported heritability
estimates for BMI are typically much higher (40-70%
[6]), a substantial proportion of the variance remains un-
accounted for. To what extent this “missing heritability”
is attributable to rare or structural variation is increas-
ingly of interest to researchers and supported by a grow-
ing list of rare copy number variants (CNV) reported to
be associated with BMI and obesity [16-24].
Given the widening spectrum of genetic variation
demonstrated to be associated with common, complex
traits, there is a need for genetic models integrating
common and rare variants. In this study, we con-
structed a model that jointly incorporated the effects
of common and rare (<1%) variants shown previously
to be associated with obesity. First, genetic variants as-
sociated with BMI and obesity were catalogued from
the literature, including common SNPs and common
and rare CNVs. Next, genetic risk sum scores (GRSS),
which summarize the total number of risk variants,
were tested for association with BMI in 1850 Americans of
European (EA) and 498 African (AA) descent from the
Study of Addiction: Genetics and Environment (SAGE).
Finally, we evaluated clinical utility of these models on
the basis of discriminative ability to predict obesity
classification.
Methods
Participants and phenotypes
Participants were from the Study of Addiction: Genes
and Environment (SAGE) [25]. All SAGE participants
provided written informed consent for genetic studies
and agreed to share their DNA and phenotypic information
for research purposes. All samples were de-identified and
only subjects who consented to health research were in-
cluded. The institutional review boards at all data collection
sites granted approval for use of the data (Washington
University in St. Louis, Henry Ford Health Sciences Center,
Indiana University, The State University of New York
Downstate Medical Center, University of Connecticut
Health Center, University of California San Diego).
Study variables were assessed by interview, using versions
of the Semi-Structured Assessment for the Genetics of
Alcoholism (SSAGA) [26]. BMI was calculated from self-
reported height and weight. Participants were removed
from data analysis if they had missing data on either height
or weight, height was < 1.4 or > 2 meters, weighed < 38 or >
166 kg, or if calculated BMI was < 14.5 or > 60 kg/m2, as
values not in these ranges were likely due to data entry er-
rors or suggestive of eating or syndromic disorders (n = 12).
Clinical bodyweight categories were defined as overweight
(BMI ≥ 25 kg/m2), obese class I (BMI ≥ 30 kg/m2), II
(BMI ≥ 35 kg/m2) and III (BMI ≥ 40 kg/m2). Age was in-
cluded as age at interview in years. Alcohol dependence
(AD) was defined by the SSAGA according to DSM-IV cri-
teria [27] and nicotine dependence (ND) was defined as
having a Fagerström Test for Nicotine Dependence score of
4 or greater as assessed from the SSAGA.
Complete data on height, weight, AD, ND, genotypes
and CNVs were available for 1850 EA and 498 AA par-
ticipants. Descriptive statistics for study variables are
presented by sex and self-reported ancestry in Table 1.
There was a significant race by sex interaction with BMI
(t-test = 6.84, p = 1.01×10−11) indicating that females and
AAs tended to have greater BMI. Males were more likely
to be AD (χ2 = 286.02, p = 3.65×10−64) and ND (χ2 =
9.36, p = 0.002). The age by AD interaction was also sig-
nificant (t-test = −3.11, p = 0.002) indicating that older
subjects were less likely to be AD.
Genotyping
Samples were genotyped on the Illumina Human 1 M
beadchip at the Center for Inherited Diseases Research at
Johns Hopkins University. Details of quality control proce-
dures have been previously reported [25]. Analysis was
restricted to SNPs with minor allele frequency ≥ 1%, call
rate ≥ 98% and Hardy-Weinberg Equilibrium p-value ≥
10−5. IMPUTE2 was used to phase the observed geno-
types and impute unobserved genotypes [28,29] using the
1000 Genomes phase 1 reference panel (release June 2011,
b37) [30] separately by ancestry. To minimize effects of
population stratification, 577,039 SNPs were used to gener-
ate ten principal components (PC) using EIGENSOFT 3.0
[31] and SMARTPCA [32]. To circumvent over-fitting only
PCs that were associated with BMI and indicative of ances-
tral background were used in subsequent analyses [31-33].
The software Quanto was used to assess the power of the
SAGE sample (n = 2,348) to detect known BMI/obesity
genetic variants [34]. These calculations were com-
puted using descriptive statistics reported in original
papers, which included variant frequency, effect size,
odds-ratio and percent variance accounted for.
CNV calling
The Illumina 1 M array has 1,072,820 probes (which in-
cludes 23,812 non-SNP “intensity-only” markers) that were
used for CNV detection. Three widely-used programs were
used for CNV calling: CNVPartition (Illumina StudioBead
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software), PennCNV [35], and QuantiSNP [36]. Genomic
waves were adjusted for CNVs called by PennCNV and
QuantiSNP [37]. Both PennCNV and QuantiSNP report a
metric score for quality control purposes and CNV calls
with a Log Bayes Factor less than ten were removed as well
as poor quality samples based on quality control measures
for CNV analysis as described in our previous work [38].
CNV calls from the three programs were compared and
integrated using Combined CNV (CNVision.org) [39]. To
increase the positive predicative rate [38], only CNVs that
were called by at least two programs, as defined by ≥
50% reciprocal overlap, were analyzed. Given that calls
in centromeric, telomeric and immunoglobin regions
are prone to harbor false positives, CNV calls in those
regions were removed from analyses (33 regions,
13941 calls) [35,40].
Selection of BMI/obesity-associated genetic variation
BMI SNPs were catalogued from a BMI meta-analyses
by Speliotes and colleagues [9]. The meta-analyses iden-
tified 32 SNPs reaching genome-wide significance (p <
5x10−8) (Additional file 1: Table S1). The SAGE sample
was not included in the meta-analysis and represents
and independent sample to test BMI loci. Fifteen SNPs
did not appear on the genotyping array. Ungenotyped
markers were ascertained by two approaches in order to
compare methods: 1) imputation and 2) proxy SNPs.
Imputed SNPs analyzed had allele frequency greater
than 1% (Additional file 1: Table S1) and imputation
quality greater than 0.8. The proxy method used the LD
structure of the genome to identify highly correlated
SNPs that appear on the array as substitutes for the
unobserved SNPs. Proxy SNPs were identified using
SNP Annotation and Proxy Search V2.1 [41] using the
HapMap release 22 CEU reference panel except for
rs11847697, which did not have a highly correlated SNP
(r2 < 0.7) and was therefore not included in SNP-GRSSs.
Proxy SNP information appears in Additional file 1:
Table S1b. BMI and obesity associated CNVs were
catalogued from research published between January 2008
and January 2012 via PubMed search (Additional file 2:
Table S2). Case reports, typical of monogenic inheritance,
were not included in the catalogue as the focus of the
current study was on common complex obesity.
BMI SNP genetic risk sum scores
Primarily two methods exist for constructing genetic
scores: count and weighted methods. The count method
is the sum of the number of risk alleles, whereas the
weighted method incorporates the sum of the number of
risk alleles each weighted by its odds-ratio or effect size.
In this study, the weighted scores were constructed from
regression coefficients reported by Speliotes et al. [9].
Count and weighted scores using the proxy method were
calculated using the profile option in PLINK [42]. If
SNP information was missing in an individual then the
scoring routine imputed expected values based on sample
allele frequency. Count and weighted scores using imputed
genotypes were constructed using R version 2.13.1(script
available upon request to R.E.P.) [43]. Furthermore, to ex-
tend existing GRSS methodology [44], count and weighted
scores were constructed using probabilities of imputed risk
alleles (p) by the equation below (Equation 1). Count scores
were calculated with β = 1 and weighted scores with β = ef-
fect size of each risk allele (A) reported by Speliotes et al.
[9] summed over the number of risk alleles in the score (n).
To determine if there was significant effect size differences
by GRSS methodology z-scores were computed in R using
Equation 2 and p-values assigned based on the standard
normal distribution.
Xn
1
β 2  p AAð Þð Þ þ p Aað Þ½ 
 !
=n ð1Þ
Z ¼ es1 − es2ð Þﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
se21 þ se22ð Þ2
p ð2Þ
CNV association
In the SAGE sample, CNVs with a frequency ≥ 1% were
considered common, those with a frequency < 1% rare.
Common BMI/obesity-associated CNVs were tested in-
dividually as well as in aggregate by count scores. The
limited number of rare CNV variants expected to be de-
tected in the SAGE sample made statistical analysis of
individual rare CNVs inappropriate [45,46]. Therefore,
rare BMI/obesity-associated CNVs were tested by aggre-
gate count scores (CNV-GRSSs). Additionally, since rare
CNV burden scores have been associated with obesity
[16,19], the genome-wide load of rare CNVs was also
tested by the count method. CNVs previously reported
to be associated with BMI/obesity were considered the
same region in the SAGE sample if the CNV boundaries
Table 1 Descriptive statistics by sex and self-reported
ancestry
Variable Men Women
Mean EA
(SD) n = 780
Mean AA
(SD) n = 231
Mean EA (SD)
n = 1070
Mean AA
(SD) n = 267
Age 40.4 (9.7) 41.1 (8.3) 39.3 (9.0) 39.3 (6.9)
BMI 27.5 (4.6) 28.4 (5.1) 26.5 (6.5) 31.5 (7.3)
n (%) n (%) n (%) n (%)
Obese 184 (23.6%) 72 (31.2%) 246 (23.0%) 130 (48.7%)
AD 501 (64.2%) 171 (74.0%) 300 (28.0%) 120 (44.9%)
ND 406 (52.1%) 125 (54.1%) 466 (43.6%) 151 (56.6%)
Note: EA = European-American, AA = African-American, SD = standard
deviation, Age = age at interview in years, BMI = body mass index kg/m2,
Obese = BMI ≥ 30 kg/m2, AD = alcohol dependence, ND = nicotine dependence.
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shared at least 40% overlap with the CNV boundaries
reported in the literature. Furthermore, since there is
evidence that the positive predictive rate is increased
for large CNVs, which is likely due to the increased
number of probes in larger variants, common and rare
scores were also constructed from CNVs ≥ 100-kb to
potentially reduce the number of false positive calls in
the score [38].
Linear models
R [43] was used to fit linear and logistic regression
models using established covariates for BMI including
PCs associated with BMI and ancestry, sex and age. AD
and ND were also included as covariates since the SAGE
sample was selected for these traits. Predictors in linear
models were included in a stepwise process and inde-
pendent variables were centered to facilitate interpret-
ation of effects. Interactions between covariates and
predictors were tested and included in the final model if
the p-value of the interaction was less than the Bonfer-
roni corrected significance level of 0.002.
Prediction of obesity
To test whether the combined model of common and
rare variation had clinical utility for obesity risk pre-
diction, we assessed diagnostic efficiency by calculating
the area under the (AUC) receiver operator criteria
(ROC) curves, which is a plot of the true positive rate
(sensitivity) against the false positive rate (1 - specifi-
city). Binary logistic regression was used to calculate
predicted probabilities of the models. SPSS Statistics
version 19.0 was used for AUC analyses and the StAR
software was used to test for statistical differences be-
tween ROC curves [47].
Results
BMI SNP-GRSS
Seven of the 32 BMI-SNPs were found to be associated
with BMI in the SAGE sample (p < 0.01), which in-
cluded SNPs in or near FTO and BDNF (Additional file 1:
Table S1). The mean number of BMI risk alleles per per-
son was 28.5 (SD = 3.4) with a range from 18 to 39 and
the distribution is presented by self-reported ancestry in
Figure 1. As shown in Table 2, the SNP-GRSS was highly
significantly associated with BMI in the combined sample
(p < 1.11×10−12) and accounted for 3.1% of the variance.
Examining GRSSs by ancestry indicated that point esti-
mates for effect size and percent of variance accounted
for in BMI tended to be greater in EA than AA sample
(Additional file 3: Table S3a). However, there were no
statistical differences in GRSS effect sizes (p > 0.138) when
comparing by ancestry (Additional file 3: Table S3b). Al-
though there were no statistical differences in effect
sizes by GRSS method, the proportion of variance in
BMI accounted for increased by 0.6-0.9% when using
weighted scores and in the EA sample an additional
0.2% when incorporating imputed genotype probabilities
(Additional file 3: Table S3c).
CNV association
Eighty-four BMI/obesity-associated CNVs were catalo-
gued from the literature and tested for association with
BMI and obesity in the SAGE sample (Additional file 2:
Table S2). Of the common CNVs, only a 21-kb deletion
on 16p12.3 showed evidence for association with BMI
(β = −0.057, p = 0.003, frequency = 16.9%). This CNV was
also nominally associated with obese class I (OR = 0.743,
p = 0.022) and II (OR = 0.630, p = 0.020). We would like to
note that this CNV is correlated with SNP rs12444979,
which was included in the GRSS (r = 0.798). However,
since they were not in perfect LD and diagnostics be-
tween them did not suggest multicolinearity (variance
inflation factor < 2.8) we chose to include both in
subsequent analyses because it is possible that the SNP
is capturing variation beyond the effect of the CNV.
Additionally, rs2815752 near NEGR1 has been previously
shown to tag a common deletion [9,48,49]. Although the
SNP (included in the SNP-GRSS) was nominally associated
(p =0.007) with BMI the CNV was not, which could be due
in part to the low call rate of this deletion in SAGE (<1%).
There were two additional common CNVs nominally asso-
ciated with class II obesity. The first was a duplication on
1p36.1 (OR = 3.1, p = 0.009, frequency 1.2%) which ranged
in length from 49.3 to 150.8 kb with a median value of
66.4 kb. The second was a large deletion on 5q13.2 (OR =
1.5, p = 0.048, frequency 7.7%) and ranged in length from
577.5 to 2238 kb with a median value of 1635 kb. None of
the CNV-GRSSs, common or rare, were significantly asso-
ciated with BMI or obesity in the SAGE sample. Descriptive
statistics as well as association results for CNV-GRSSs are
presented in Additional file 4: Table S4.
Models incorporating effects of SNPs and CNVs
Results from linear regression analyses are displayed in
Table 3. Model 1, which included the standard covari-
ates, PC1 by sex and age by AD interactions but no gen-
etic component, accounted for 8.3% of the variance in
BMI. Model 2, which added the SNP-GRSS and the 21-
kb deletion on 16p12.3 to the base model, fit signifi-
cantly better [F(3 2335) = 25.3, p = 3.34x
−54] and accounted
for an additional 3.2% of phenotypic variance (3.1% due
to SNP-GRSS, 0.1% due to deletion on 16p12.3) in BMI
for a total of 11.5%. Interactions between the covariates
and the SNP-GRSS were not significant except for sex,
which suggested that the SNP-GRSS was statistically
similar in EA and AA and across age but tended to ac-
count for more of the variation in females. No signifi-
cant interactions between the covariates and the 21-kb
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Figure 1 Distribution of BMI-risk alleles by ancestry. Note: BMI = body mass index kg/m2.
Table 2 Comparison of the association of GRSSs with BMI constructed by count and weighted methods
GRSS Method Mean (SD) ES (SE) T p-value R2
1. Proxy count 0.450 (0.06) 0.927 (0.129) 7.18 9.07×10−13 0.022
2. Proxy weighted 0.063 (0.01) 1.104 (0.129) 8.56 2.05×10−17 0.027
3. Imputed count 0.447 (0.05) 0.865 (0.121) 7.16 1.11×10−12 0.022
4. Imputed weighted 0.062 (0.01) 1.035 (0.122) 8.51 2.94×10−17 0.030
5. Imputed probability count 0.894 (0.11) 0.872 (0.121) 7.21 7.33×10−13 0.022
6. Imputed probability weighted 0.124 (0.02) 1.037 (0.122) 8.54 2.43×10−17 0.031
Note: BMI = body mass index kg/m2, GRSS = genetic risk sum score, Mean =mean GRSS, ES = effect size for GRSS, Count = GRSS constructed from the summation
of the number of risk alleles, Weighted = GRSS constructed from the number of risk alleles weighted by effect-sizes reported in Speliotes et al. 2010, SNP = single
nucleotide polymorphism, Proxy = highly correlated substitute SNPs were used for variants not directly genotyped, Imputed = genotypes inferred from 1000
Genomes reference panel, Imputed probability = probability of genotypes inferred from 1000 Genomes reference panel.
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deletion on 16p12.3 were found, which indicated that
the CNV was comparably associated with BMI in males
and females, EA and AA and across the age range ob-
served in SAGE. Additional file 5: Table S5 gives full model
statistics by ancestry. We have also included in Additional
file 5: Table S5d models with the two SNPs (rs12444979,
rs2815752) that have been previously shown to tag
CNVs removed from the SNP-GRSS and did not find
any major differences in model fit (i.e.; [F(12 2,335) =
25.34, p-value = 3.34×10−54, R2 = 0.115] vs. [F(12 2,335) =
24.54, p-value = 1.97×10−52, R2 = 0.112]).
Obesity risk prediction
To test the discriminative accuracy of models to predict
obesity classification, ROC curves were plotted and the
corresponding AUCs were calculated. Three sets of
nested models were tested: 1) covariates (PCs, sex, age,
ancestry by sex interaction), 2) covariates, SNP-GRSS
and interaction with sex and 3) covariates, SNP-GRSS
and three obesity-associated CNVs (the 21 kb deletion
on 16p.12.3, the 66 kb duplication on 1p36.1, and the
1440 kb deletion on 5q13.2). Table 4 displays fit statistics
from ROC curve analysis by BMI category (Additional
file 6: Table S6 displays by ancestry). AUC estimates in-
dicated the models significantly predicted overweight
and obesity classification with maximum discriminative
ability when employing model 3 to predict class III obes-
ity (AUC = 0.750, 95% CI = [0.702, 0.797]). Models that
included genetic information had significantly greater
AUCs than models only including covariates (Table 4).
Discussion and conclusions
We have constructed an integrated model of common
and rare variation catalogued from the literature and
demonstrated its association with BMI in 1850
European-American and 498 African-American SAGE
participants. This study is among the first to incorporate
both SNPs and CNVs in a joint genetic analysis of BMI
Table 3 Linear models predicting BMI
Model Estimate EA Estimate AA Estimate combined p-value EA p-value AA p-value combined
Model 1: Covariates
Intercept 26.91 30.21 27.63 < 2×10−16 < 2×10−16 < 2×10−16
PC1 −50.11 −6.91 −98.82 0.788 0.939 2.40×10−29
PC4 19.31 −29.93 10.54 0.027 0.157 0.167
PC8 −3.18 −28.41 −30.20 0.934 0.008 0.002
Sex −1.26 2.49 −0.46 1.76×10−5 3.67×10−5 0.081
Age 0.05 −0.01 0.04 2.13×10−4 0.984 9.45×10−4
AD −0.15 −0.37 −0.20 0.062 0.018 0.004
ND −0.10 0.07 −0.06 0.157 0.627 0.361
PC1*Sex 295.12 −249.00 −122.29 0.409 0.172 1.92×10−12
Age*AD −0.02 −0.07 −0.02 0.026 0.0006 3.20×10−4
Model 2: Covariates, GRSS & CNV
Intercept 26.91 30.22 27.63 < 2×10−16 < 2×10−16 < 2×10−16
PC1 −107.10 −14.09 −110.22 0.560 0.877 1.89×10−35
PC4 20.20 −30.04 10.14 0.019 0.153 0.176
PC8 11.44 −30.56 −31.53 0.765 0.004 8.36×10−4
Sex −1.24 2.51 −0.43 1.70×10−5 2.89×10−5 0.099
Age 0.05 0.01 0.04 2.03×10−4 0.963 8.15×10−4
AD −0.15 −0.37 −0.20 0.058 0.020 0.005
ND −0.12 0.09 −0.07 0.087 0.566 0.253
PC1*Sex 170.80 −261.80 −131.38 0.627 0.150 3.91×10−14
Age*AD −0.01 −0.06 −0.02 0.032 0.001 6.59×10−4
SNP-GRSS 65.40 42.30 62.44 2.55×10−15 0.036 4.30×10−16
Sex*SNP-GRSS 39.96 70.47 44.37 0.014 0.076 0.003
Del 16p12.3 −0.60 −0.61 −0.57 0.079 0.511 0.075
Note: BMI = body mass index kg/m2, Estimate = regression coefficient, EA = European-American, AA =African-American, GRSS = genetic risk sum score, PC = principal
component score, Age = age at interview in years, AD = alcohol dependence, ND=nicotine dependence, CNV= copy number variation, Del = deletion.
* = interaction term.
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and obesity risk prediction. Our best- fitting model
included standard covariates, SNP-GRSS and a 21-kb
deletion on 16p12.3, and accounted for 11.5% of the
phenotypic variance in BMI (p = 3.34×10−54).
The effects of 32 BMI-associated SNPs were incorpo-
rated via an aggregate risk score and accounted for up to
3.1% of the variance in BMI. Comparison of SNP-GRSS
methodology indicated that a weighted score resulted in
a 0.6-0.9% increase in the amount of variance accounted
for. Furthermore, in the EA sample incorporating the
probability of risk alleles from imputation further in-
creased the amount of variance accounted for in BMI.
The effect of the score tended to be lower in the AA
sample. Due to the limited sample size of the AA group
it could not be determined with confidence if indeed the
effect of the score on BMI differed by ancestry. However,
a study by Belsky et al. report that a genetic score of
BMI-associated SNPs tended to be less significant in an
AA sample compared to those from the EA sample [50].
These findings highlight the value of large-scale meta-
analysis validation efforts to characterize effect sizes for
genetic variants. Future research should test these methods
for improved risk prediction in other complex traits and
diseases and in diverse populations.
Of 84 BMI/obesity-associated CNVs catalogued from
the literature, only 46 were detected in SAGE and only
one, 16p12.3 deletion, was significantly associated with
BMI. Speliotes et al. first reported the 16p12.3 deletion
in a large-scale meta-analysis because a common BMI-
decreasing allele was highly correlated with the same
21 kb deletion [9]. In the present study, the CNV was
also moderately associated with obesity classes I and II.
Additionally, two common CNVs on 1p36.1 and 5q13.2
were nominally associated with class II obesity. Our results
did not yield additional support for the other BMI/obesity-
associated CNVs, which might reflect limited power in the
SAGE sample to detect the range of effect sizes, even when
aggregate effects were considered. However, only 4 of the
84 CNVs identified from the literature have been associated
with BMI/obesity in multiple studies. To that point, a re-
cent study by Walters et al. attempted to replicate 18 BMI/
obesity-associated CNVs and only replicated a rare 220 kb
deletion on 16p11.2 [51]. Therefore, it is conceivable that
the collections of CNVs examined here contained a greater
number of false positives than true variants, thereby redu-
cing the potential for replication by a risk score. Large-scale
BMI/obesity-associated CNV meta-analyses are needed to
validate reported variants and to accurately characterize the
magnitude of their effects.
We also assessed whether the integrated models were
clinically useful for obesity risk prediction. A model
including standard covariates, SNP-GRSS and three
obesity-associated CNVs demonstrated significant dis-
criminative ability to predict overweight and obesity
Table 4 Discriminative accuracy of covariates, SNP-GRSS and CNV predicting BMI category in European- and
African-Americans
Model AUC 95% CI Asy. Sig. of Model Δ AUC % Δ AUC p Δ AUC
Overweight: n = 1443 (61.4%)
1. Covariates 0.679 [0.657,0.700] 2.68×10−48 - - -
2. Model 1 + SNP-GRSS 0.692 [0.671,0.714] 9.23×10−56 0.013 1.91% 0.001
3. Model 2 + CNV 0.694 [0.672,0.715] 1.27×10−56 0.002 0.28% 0.372
Obese Class I: n = 632 (26.9%)
1. Covariates 0.621 [0.594,0.647] 2.74×10−19 - - -
2. Model 1 + SNP-GRSS 0.661 [0.637,0.686] 2.77×10−33 0.040 6.44% 0.0001
3. Model 2 + CNV 0.662 [0.638,0.687] 1.12x10−33 0.001 0.15% 0.662
Obese Class II: n = 264 (11.2%)
1. Covariates 0.648 [0.610,0.685] 5.22×10−15 - - -
2. Model 1 + SNP-GRSS 0.681 [0.646,0.716] 6.97×10−22 0.033 5.09% 0.025
3. Model 2 + CNV 0.690 [0.656,0.725] 5.58×10−24 0.009 1.32% 0.123
Obese Class III: n = 106, (4.5%)
1. Covariates 0.711 [0.660,0.762] 1.97×1013 - - -
2. Model 1 + SNP-GRSS 0.741 [0.692,0.790] 4.81×10−17 0.030 4.22% 0.029
3. Model 2 + CNV 0.750 [0.702,0.797] 3.15×10−18 0.009 1.21% 0.152
Note: BMI = body mass index kg/m2, SNP = single nucleotide polymorphism, SNP-GRSS = genetic risk sum score constructed from imputed probability of carrying
32 BMI-associated SNPs weighted by effect size reported in Speliotes et al. 2010, CNV = copy number variation, AUC = area-under the receiver operator criteria
curve, Asy. Sig. = asymptotic significance, Δ AUC = change in AUC from previous model, % Δ AUC = percent change in AUC from previous model, p Δ AUC = statistical
significance of change in AUC, Overweight = BMI ≥ 25 kg/m2, Obese I = BMI ≥ 30 kg/m2, Obese II = BMI ≥ 35 kg/m2, Obese III = BMI ≥ 40 kg/m2, Covariates = PC1, PC4, PC8,
sex, age, AD, ND, PC1*sex, age*AD, PC = principal component score, Age = age at interview, AD= alcohol dependence, ND= nicotine dependence.
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classification, with maximum discriminative ability when
predicting class III obesity (AUC= 0.750). Other studies
using SNP-GRSS to predict obesity have incorporated 8–32
SNPs and reported AUC estimates ranging from 0.574 to
0.597 [9,50,52-54]. Although our AUC estimates were sta-
tistically significant, they fell short of the threshold used in
clinical practice for screening (0.8) and an important
extension of this work is model validation in independent
samples.
There are several possible extensions of the work pre-
sented here. First, SAGE participants consisted of a se-
lected sample for substance-use behaviors. Although we
have included AD and ND as covariates in all analyses,
research has shown these phenotypes to have complex
relationships with body composition [55,56], and this
may complicate interpretation. Future research should
test for associations in both larger and population-based
samples. An additional extension of this work is to in-
corporate variation detected from other obesity pheno-
types such as waist-to-hip ratio [57,58], extremes of the
BMI trait distribution [59], and from diverse populations
[14]. Additionally, fine mapping efforts are needed and
will likely identify lower-frequency variants, which are
typically not genotyped on commercial GWAS-arrays.
Therefore a further extension of the work presented here
is to include lower-frequency SNPs and INDELs identi-
fied by large-scale exome and genome sequencing ef-
forts. Another important extension of an integrated
model of BMI and obesity is to incorporate the moderat-
ing effects of the environment. At least two of the BMI-
validated SNPs exhibit gene by environment interactions
(GxE) [60,61]. For example, a large meta-analysis found
that in physically active adults the effect of the FTO risk
allele on obesity was attenuated by 27% [62]. Given
the considerable impact of the environment on body
composition, future research needs to incorporate en-
vironmental variables into models of disease and risk
prediction. Despite the potential limitations of the
current study, this work provides a framework for inte-
grating common and rare variation as both an alterna-
tive form of replication of genetic effects as well as for
risk prediction of complex traits.
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